171 related articles for article (PubMed ID: 31387789)
1. A glycal-based photoaffinity probe that enriches sialic acid binding proteins.
Thuy-Boun PS; Wolan DW
Bioorg Med Chem Lett; 2019 Sep; 29(18):2609-2612. PubMed ID: 31387789
[TBL] [Abstract][Full Text] [Related]
2. Saturation transfer difference (STD) 1H-NMR experiments and in silico docking experiments to probe the binding of N-acetylneuraminic acid and derivatives to Vibrio cholerae sialidase.
Haselhorst T; Wilson JC; Thomson RJ; McAtamney S; Menting JG; Coppel RL; von Itzstein M
Proteins; 2004 Aug; 56(2):346-53. PubMed ID: 15211517
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of novel 3-C-alkylated-Neu5Ac2en derivatives as probes of influenza virus sialidase 150-loop flexibility.
Rudrawar S; Kerry PS; Rameix-Welti MA; Maggioni A; Dyason JC; Rose FJ; van der Werf S; Thomson RJ; Naffakh N; Russell RJ; von Itzstein M
Org Biomol Chem; 2012 Nov; 10(43):8628-39. PubMed ID: 22976385
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and anti-influenza evaluation of polyvalent sialidase inhibitors bearing 4-guanidino-Neu5Ac2en derivatives.
Honda T; Yoshida S; Arai M; Masuda T; Yamashita M
Bioorg Med Chem Lett; 2002 Aug; 12(15):1929-32. PubMed ID: 12113811
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of delta4-beta-D-glucopyranosiduronic acids as mimetics of 2,3-unsaturated sialic acids for sialidase inhibition.
Florio P; Thomson RJ; Alafaci A; Abo S; von Itzstein M
Bioorg Med Chem Lett; 1999 Jul; 9(14):2065-8. PubMed ID: 10450982
[TBL] [Abstract][Full Text] [Related]
6. 2-Deoxy-2,3-didehydro-N-acetylneuraminic acid analogues structurally modified at the C-4 position: synthesis and biological evaluation as inhibitors of human parainfluenza virus type 1.
Ikeda K; Sato K; Kitani S; Suzuki T; Maki N; Suzuki Y; Sato M
Bioorg Med Chem; 2006 Dec; 14(23):7893-7. PubMed ID: 16908163
[TBL] [Abstract][Full Text] [Related]
7. Novel 3,4-disubstituted-Neu5Ac2en derivatives as probes to investigate flexibility of the influenza virus sialidase 150-loop.
Rudrawar S; Dyason JC; Maggioni A; Thomson RJ; von Itzstein M
Bioorg Med Chem; 2013 Aug; 21(16):4820-30. PubMed ID: 23800724
[TBL] [Abstract][Full Text] [Related]
8. Preparation of a fluorous protecting group and its application to the chemoenzymatic synthesis of sialidase inhibitor.
Ikeda K; Mori H; Sato M
Chem Commun (Camb); 2006 Aug; (29):3093-4. PubMed ID: 16855696
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of 4-O-alkylated 2-deoxy-2,3-didehydro-N-acetylneuraminic acid derivatives as inhibitors of human parainfluenza virus type-3 sialidase activity.
Tindal DJ; Dyason JC; Thomson RJ; Suzuki T; Ueyama H; Kuwahara Y; Maki N; Suzuki Y; von Itzstein M
Bioorg Med Chem Lett; 2007 Mar; 17(6):1655-8. PubMed ID: 17236768
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and anti-influenza virus activity of 4-guanidino-7-substituted Neu5Ac2en derivatives.
Honda T; Masuda T; Yoshida S; Arai M; Kobayashi Y; Yamashita M
Bioorg Med Chem Lett; 2002 Aug; 12(15):1921-4. PubMed ID: 12113809
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of human parainfluenza virus type 1 sialidase by analogs of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid.
Suzuki T; Ikeda K; Koyama N; Hosokawa C; Kogure T; Takahashi T; Jwa Hidari KI; Miyamoto D; Tanaka K; Suzuki Y
Glycoconj J; 2001 Apr; 18(4):331-7. PubMed ID: 11788801
[TBL] [Abstract][Full Text] [Related]
12. A facile synthesis of 2-deoxy-2,3-didehydroneuraminic acid derivatives.
Ikeda K; Konishi K; Sano K; Tanaka K
Chem Pharm Bull (Tokyo); 2000 Jan; 48(1):163-5. PubMed ID: 10705498
[TBL] [Abstract][Full Text] [Related]
13. Uronosyl phosphonate-based sialidase inhibitor synthesis and conformational analysis.
Bhatt B; Thomson RJ; von Itzstein M
Bioorg Med Chem Lett; 2012 Dec; 22(24):7623-6. PubMed ID: 23122861
[TBL] [Abstract][Full Text] [Related]
14. 2-Deoxy-2,3-didehydro-N-acetylneuraminic acid analogs structurally modified by thiocarbamoylalkyl groups at the C-4 position: Synthesis and biological evaluation as inhibitors of human parainfluenza virus type 1.
Ikeda K; Sato K; Nishino R; Aoyama S; Suzuki T; Sato M
Bioorg Med Chem; 2008 Jul; 16(14):6783-8. PubMed ID: 18555688
[TBL] [Abstract][Full Text] [Related]
15. Development of miracle medicines from sialic acids.
Ogura H
Proc Jpn Acad Ser B Phys Biol Sci; 2011; 87(6):328-61. PubMed ID: 21670567
[TBL] [Abstract][Full Text] [Related]
16. STD NMR spectroscopy and molecular modeling investigation of the binding of N-acetylneuraminic acid derivatives to rhesus rotavirus VP8* core.
Haselhorst T; Blanchard H; Frank M; Kraschnefski MJ; Kiefel MJ; Szyczew AJ; Dyason JC; Fleming F; Holloway G; Coulson BS; von Itzstein M
Glycobiology; 2007 Jan; 17(1):68-81. PubMed ID: 16973731
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of a novel, versatile sialidase from a Sphingobacterium that can hydrolyze the glycosides of any sialic acid species at neutral pH.
Iwaki Y; Matsunaga E; Takegawa K; Sato C; Kitajima K
Biochem Biophys Res Commun; 2020 Mar; 523(2):487-492. PubMed ID: 31889533
[TBL] [Abstract][Full Text] [Related]
18. Streptococcus pneumoniae Sialidase SpNanB-Catalyzed One-Pot Multienzyme (OPME) Synthesis of 2,7-Anhydro-Sialic Acids as Selective Sialidase Inhibitors.
Xiao A; Slack TJ; Li Y; Shi D; Yu H; Li W; Liu Y; Chen X
J Org Chem; 2018 Sep; 83(18):10798-10804. PubMed ID: 30105908
[TBL] [Abstract][Full Text] [Related]
19. Syntheses of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid analogues modified by N-sulfonylamidino groups at the C-4 position and biological evaluation as inhibitors of human parainfluenza virus type 1.
Nishino R; Ikeda K; Hayakawa T; Takahashi T; Suzuki T; Sato M
Bioorg Med Chem; 2011 Apr; 19(7):2418-27. PubMed ID: 21382718
[TBL] [Abstract][Full Text] [Related]
20. High efficiency method of detection and isolation of neuraminidase inhibitor resistant influenza viruses by fluorescence sialidase imaging.
Kurebayashi Y
Jpn J Antibiot; 2016 Dec; 69(6):357-366. PubMed ID: 30226930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
